Skip to main content

Closed

AEON: AEON Biopharma, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-823.7%

Financially safe

Stretched

Debt / equity-0.16×

Interest coverage0.0×

Current ratio0.99×

AEON Biopharma, Inc.

AEONNew York Stock Exchange Arca·USD·Closed

AEON Biopharma, Inc.

AEONNew York Stock Exchange Arca·USD·Closed

$0.30

+0.34%

$0.30

+$0.00 (0.34%)

52W Range

6thpctl

Volume

0.40×avg

Mkt Cap

3.50MUSD

P/E

-0.1TTM

Div Yield

–ann

52W Range

6thpctl

Volume

0.40×avg

Market Cap

3.50MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings